miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients
Ovarian cancer (OC) remains a leading cause of gynecological cancer‐related death worldwide, characterized by poor 5‐year survival. Molecular markers could serve as crucial tools of personalized prognosis and therapy. Herein, we present miR‐181a as novel predictor of OC prognosis, using five indepen...
Uložené v:
| Vydané v: | International Journal of Cancer Ročník 147; číslo 12; s. 3560 - 3573 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Hoboken, USA
Wiley
15.12.2020
John Wiley & Sons, Inc Wiley Subscription Services, Inc |
| Predmet: | |
| ISSN: | 0020-7136, 1097-0215, 1097-0215 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
Buďte prvý, kto okomentuje tento záznam!